Skip to content
Homepage
Author:
Tevogen Bio Inc
Posted Date:
June 9, 2026
Tevogen Announces Formation of a Healthcare Services Initiative
Tevogen Bio Inc
June 9, 2026
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
Tevogen Bio Inc
May 29, 2026
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
Tevogen Bio Inc
May 28, 2026
Letter to Shareholders from CEO Dr. Ryan Saadi
Tevogen Bio Inc
May 28, 2026
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
Tevogen Bio Inc
May 27, 2026
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
Tevogen Bio Inc
May 25, 2026
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
Tevogen Bio Inc
May 21, 2026
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
Tevogen Bio Inc
May 21, 2026
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
Tevogen Bio Inc
May 21, 2026
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
Tevogen Bio Inc
May 20, 2026
1
2
Next
